3,224 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4503

Astellas Pharma
JP¥1,584.50-1.2%-18.4%JP¥2.8tJP¥2,093.33PE676.7xE30.0%4.4%

600436

Zhangzhou Pientzehuang Pharmaceutical
CN¥220.10-4.5%-22.0%CN¥132.8bCN¥293.53PE47.7xE20.3%0.6%

RPRX

Royalty Pharma
US$29.452.3%-18.4%US$17.8bUS$45.62PE11.6xE5.9%2.9%

AVTR

Avantor
US$25.561.1%20.1%US$17.6bUS$27.75PE54.1xE27.2%n/a

603259

WuXi AppTec
CN¥43.80-7.4%-49.2%CN¥123.7bCN¥74.98PE13.3xE9.7%2.2%

BMRN

BioMarin Pharmaceutical
US$90.214.0%-7.9%US$16.9bUS$109.83PE102.1xE30.4%n/a

GALD

Galderma Group
CHF62.99-1.3%n/aCHF15.0bn/an/an/an/a

BGNE

BeiGene
US$149.76-1.4%-41.2%US$16.1bUS$268.64PS6.4xE56.2%n/a

TEVA

Teva Pharmaceutical Industries
US$13.85-1.9%48.0%US$15.7bUS$15.15PB2.1xE46.5%0%

VTRS

Viatris
US$11.71-2.6%19.2%US$14.0bUS$12.40PE254.2xE16.0%4.1%

300122

Chongqing Zhifei Biological Products
CN¥42.04-7.1%-24.1%CN¥100.9bCN¥71.15PE11.9xE19.0%0.8%

NBIX

Neurocrine Biosciences
US$138.090.4%34.1%US$13.8bUS$152.09PE55xE26.6%n/a

CIPLA

Cipla
₹1,422.95-2.5%55.4%₹1.1t₹1,448.74PE31xE11.7%0.6%

RVTY

Revvity
US$107.905.4%-19.7%US$13.7bUS$123.11PE74.3xE24.1%0.3%

4507

Shionogi
JP¥7,383.00-2.7%21.6%JP¥2.1tJP¥7,713.08PE13.6xE-0.6%2.0%

EXAS

Exact Sciences
US$73.601.1%13.4%US$13.5bUS$88.49PS5.3xE61.5%n/a

CRL

Charles River Laboratories International
US$247.49-4.6%22.8%US$13.2bUS$270.67PE26.8xE11.4%n/a

603392

Beijing Wantai Biological Pharmacy Enterprise
CN¥74.1615.4%-10.8%CN¥94.1bCN¥75.15PE75.4xE71.1%0.4%

KRTX

Karuna Therapeutics
US$329.833.3%80.7%US$12.6bUS$326.92PS19238.9xE60.1%n/a

MEDP

Medpace Holdings
US$397.720.4%109.8%US$12.5bUS$402.04PE43.6xE14.7%n/a

538

Yunnan Baiyao GroupLtd
CN¥50.70-1.1%-9.2%CN¥90.5bCN¥62.33PE22.1xE9.5%4.1%

INCY

Incyte
US$55.00-0.6%-25.6%US$12.4bUS$76.10PE20.7xE20.0%n/a

BRKR

Bruker
US$88.53-2.7%8.9%US$12.4bUS$85.20PE28.5xE2.5%0.2%

ERF

Eurofins Scientific
€60.04-2.2%-3.9%€11.5b€59.28PE45xE19.7%0.8%
Page 3 of 135
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.